Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Catalent, Inc. (CTLT)  
$55.37 0.12 (0.22%) as of 4:30 Fri 5/17


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 207,851,000
Market Cap: 11.51(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $32.14 - $59.82
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Catalent is a holding company. Through its subsidiaries, Co. has two operating and reporting segments: Biologics and Pharma and Consumer Health. The Biologics segment provides development and manufacturing for biologic proteins; cell, gene, and other nucleic acid therapies; plasmid DNA; induced pluripotent stem cells; and vaccines. The Pharma and Consumer Health segment comprises Co.'s capabilities for oral solids, softgel formulations, Zydis® fast-dissolve technologies, and gummy, soft chew, and lozenge dosage forms; formulation, development, and manufacturing platforms for oral, nasal, inhaled, and topical dose forms; and clinical trial development and supply services.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 1,000 1,000
Total Buy Value $0 $0 $49,980 $49,980
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 387 387 11,063 116,582
Total Sell Value $21,749 $21,749 $512,581 $11,151,362
Total People Sold 1 1 12 18
Total Sell Transactions 1 1 25 69
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 821
  Page 18 of 33  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Whitlow Ricci S President, CSS   •       –      –    2020-01-20 4 A $0.00 $0 D/D 2,464 2,464     -
   Grippo Michael J SVP, Strategy & Corp. Dev.   •       –      –    2020-01-13 4 AS $58.00 $97,440 D/D (1,680) 11,647 32%     
   Flynn Karen Pres. Biologics & CCO   •       –      –    2020-01-08 4 A $0.00 $0 D/D 35,286 35,286     -
   Grippo Michael J SVP, Strategy & Corp. Dev.   •       –      –    2019-12-20 4 AS $56.00 $134,736 D/D (2,406) 13,327     -
   Grippo Michael J SVP, Strategy & Corp. Dev.   •       –      –    2019-12-19 4 AS $54.00 $99,684 D/D (1,846) 15,733     -
   Maselli Alessandro President & COO   •       –      –    2019-12-16 4 AS $53.18 $386,512 D/D (7,268) 12,802     -
   Chiminski John R Chair & CEO   •       •      –    2019-12-11 4 GD $0.00 $0 D/D 9,650 214,607     -
   Pravda Ricardo SVP & Chief HR Officer   •       –      –    2019-11-26 4 S $52.71 $137,718 D/D (2,612) 10,846     -
   Gennadios Aristippos President Softgel & Oral Tech   •       –      –    2019-11-25 4 AS $52.55 $2,378,203 D/D (45,256) 44,241     -
   Gennadios Aristippos President Softgel & Oral Tech   •       –      –    2019-11-25 4 D $52.55 $4,131,218 D/D (78,615) 89,497     -
   Gennadios Aristippos President Softgel & Oral Tech   •       –      –    2019-11-25 4 OE $12.14 $2,272,760 D/D 123,880 100,355     -
   Grippo Michael J SVP, Strategy & Corp. Dev.   •       –      –    2019-11-22 4 AS $52.00 $19,552 D/D (376) 10,702     -
   Grippo Michael J SVP, Strategy & Corp. Dev.Offi   •       –      –    2019-10-30 3/A IO $0.00 $0 D/D 0 16,026     -
   Grippo Michael J SVP, Strategy & Corp. Dev.Offi   •       –      –    2019-10-30 3 IO $0.00 $0 D/D 0 11,078     -
   Chiminski John R Chair & CEO   •       •      –    2019-10-07 4 AS $48.84 $4,739,580 D/D (97,043) 224,257     -
   Chiminski John R Chair & CEO   •       •      –    2019-10-07 4 D $48.84 $1,664,907 D/D (34,089) 321,300     -
   Chiminski John R Chair & CEO   •       •      –    2019-10-07 4 OE $24.26 $1,160,409 D/D 47,552 348,387     -
   Lucier Gregory T Director   –       •      –    2019-09-09 4 B $51.64 $103,280 D/D 2,000 38,921 2.39     -
   Maselli Alessandro President & COO   •       –      –    2019-09-09 4 D $52.48 $173,132 D/D (3,299) 20,070     -
   Lucier Gregory T Director   –       •      –    2019-09-05 4 GA $0.00 $0 I/I 5,068 5,068     -
   Lucier Gregory T Director   –       •      –    2019-09-05 4 GD $0.00 $0 D/D 5,068 36,921     -
   Kreuzburg Christa Director   –       •      –    2019-08-23 4 D $53.15 $66,703 D/D (1,255) 6,930     -
   Zippelius Peter Director   –       •      –    2019-08-22 4 A $0.00 $0 D/D 3,167 3,642     -
   Gennadios Aristippos President, Softgel Tech.   •       –      –    2019-08-22 4 D $55.24 $210,188 D/D (3,805) 44,232     -
   Gennadios Aristippos President, Softgel Tech.   •       –      –    2019-08-22 4 A $0.00 $0 D/D 12,420 48,037     -

  821 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 18 of 33
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed